Revolutionizing Poultry Health: The Evolution of Gut Health and the Role of PATENT CO & Agromed at IPPE 2025

Over the past two decades, the understanding of gut health has evolved significantly, especially in the poultry industry...

Over the past two decades, the understanding of gut health has evolved significantly, especially in the poultry industry. Advances in research have transformed our knowledge of how gut health impacts overall bird welfare, performance, and productivity. Today, more than ever, industry leaders are emphasizing the importance of a balanced gut microbiome, focusing on its critical role in immune function, inflammation control, and nutrient absorption.

At the forefront of this evolution, PATENT CO & Agromed are leading the charge with groundbreaking innovations that promise to redefine poultry welfare. One of the key technologies making waves is their use of lignans, plant-derived compounds known for their powerful antioxidant properties. These lignans play a significant role in reducing oxidative stress and inflammation in poultry, two major factors that influence bird health and performance. With this advanced approach, PATENT CO & Agromed are not only improving bird health but also enhancing overall productivity in the poultry industry.

A prime example of these innovations will be showcased at IPPE 2025, where PATENT CO. & Agromed will present MYCORAID, a cutting-edge solution that revolutionizes mycotoxin risk management. Mycotoxins, often present in feed ingredients, are a growing concern in poultry farming due to their potential to cause health issues and negatively impact bird performance. MYCORAID is designed to mitigate these risks by neutralizing harmful mycotoxins, reducing their effects on the birds, and optimizing overall farm costs. What sets MYCORAID apart is its unique formulation that actively targets emerging mycotoxins, making it a critical tool in ensuring poultry health and productivity.